Ticlopidine
- Generic Name
- Ticlopidine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C14H14ClNS
- CAS Number
- 55142-85-3
- Unique Ingredient Identifier
- OM90ZUW7M1
- Background
Ticlopidine is an effective inhibitor of platelet aggregation. It is a prodrug that is metabolised to an active form, which blocks the ADP receptor that is involved in GPIIb/IIIa receptor activation leading to platelet aggregation. Ticlopidine is marketed under the brand name Ticlid and is indicated for patients who cannot take aspirin or in whom aspirin has...
- Indication
Used in patients, who have had a stroke or stroke precursors and who cannot take aspirin or aspirin has not worked, to try to prevent another thrombotic stroke.
- Associated Conditions
- Stroke, Thrombosis (Stent Thrombosis), Thrombotic Stroke, Subacute stent thrombosis
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath